Immunizations
FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations rise
A health-care worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images The Food and Drug Administration on Monday approved updated Covid vaccines from Pfizer and Moderna, putting the shots on track to reach […]
Read More
Moderna says updated Covid vaccine was effective against highly mutated BA.2.86 variant in trial
Artur Widak | Nurphoto | Getty Images Moderna‘s new Covid vaccine produced a strong immune response against BA.2.86, a highly mutated omicron variant that health officials are watching closely, according to clinical trial data the biotech company released Wednesday. The updated shot produced an 8.7-fold increase in protective antibodies against BA.2.86, which has been detected […]
Read More
FDA approves Pfizer maternal RSV vaccine for infants
CFOTO | Future Publishing | Getty Images The Food and Drug Administration on Monday approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S. Pfizer’s RSV shot is already approved and available in the U.S. for older adults. It’s now the second treatment […]
Read More
New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variant
A pharmacist prepares to administer Covid-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center in Chicago, Illinois, Sept. 9, 2022. Scott Olson | Getty Images New Covid vaccines from Pfizer, Moderna and Novavax will likely provide protection against the new “Eris” variant, now the […]
Read More
Moderna shares rise on better Covid vaccine outlook despite sharp drop in sales
Artur Widak | Nurphoto | Getty Images Shares of Moderna rose Thursday after the biotech company hiked its full-year outlook for its Covid vaccine, its only marketable product, despite reporting a quarterly loss and sharp drop in revenue. Here are Moderna’s results: Loss per share: $3.62 (That may not be comparable to the $4.04 expected by […]
Read More
New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
A pharmacist delivers a COVID-19 booster dose at a Chicago CVS store. Antonio Perez | Tribune News Service | Getty Images A new round of Covid vaccines is coming to the U.S. this fall — but many Americans may not roll up their sleeves and take one. That’s largely because pandemic fatigue, the belief that […]
Read More
Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results
Streptococcus agalactiae bacteria, responsible for vaginal and urinary tract infections and newborn infections including meningitis and septicemia. Optical microscopy view. Cavallini James | BSIP | Universal Images Group | Getty Images Pfizer on Wednesday said its experimental vaccine targeting the potentially deadly bacterial disease Group B Streptococcus returned strong mid-stage clinical trial results, a promising […]
Read More
Biden administration to provide free Covid vaccines to uninsured Americans this fall through end of 2024
A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images The Biden administration on Thursday announced a program to provide free Covid vaccines to uninsured Americans through December 2024 after […]
Read More
Biden administration asks Pfizer, Moderna and Novavax for ‘reasonable’ prices on updated Covid vaccines
A nurse prepares doses of the Pfizer vaccine on Dec. 30, 2021, during a COVID-19 vaccination event at Josephine’s Southern Cooking in Chatham, Illinois. Brian Cassella | Tribune News Service | Getty Images The Biden administration on Thursday urged Pfizer, Moderna and Novavax to price their updated Covid vaccines at a “reasonable” rate when they […]
Read More
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
Respiratory syncytial virus vial. Manjurul | Istock | Getty Images The Centers for Disease Control and Prevention on Thursday recommended that adults ages 60 and above receive a single dose of RSV vaccines from Pfizer and GSK after consulting their doctors. Outgoing CDC Director Rochelle Walensky signed off on the recommendation, which an advisory panel […]
Read More